Publications by authors named "Sandra L Jimmo"

Claim this Profile
P
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation.
Daniel Palmer, Sandra L Jimmo, Daniel R Raymond, Lindsay S Wilson, Rhonda L Carter

J Biol Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.
Donald H Maurice, Daniel Palmer, Douglas G Tilley, Heather A Dunkerley, Stuart J Netherton, Sandra L Jimmo

Mol Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues.
Heather A Dunkerley, Douglas G Tilley, Daniel Palmer, Hanguan Liu, Sandra L Jimmo

Mol Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Stuart J Netherton, Sandra L Jimmo, Daniel Palmer, Douglas G Tilley, Heather A Dunkerley

Diabetes· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis